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Background: Both carotid-femoral (cf) pulse wave velocity (PWV) and brachial-ankle (ba) PWV employ arterial sites
that are not consistent with the path of blood flow. Few previous studies have reported the differential characteristics
between cfPWV and baPWV by simultaneously comparing these with measures of pure central (aorta) and peripheral
(leg) arterial stiffness, i.e., heart-femoral (hf) PWV and femoral-ankle (fa) PWV in healthy populations. We aimed to
identify the degree to which these commonly used measures of cfPWV and baPWV correlate with hf PWV and faPWV,
respectively, and to evaluate whether both cf PWV and baPWV are consistent with either hf PWV or fa PWV in their
associations with cardiovascular (CV) risk factors.
Methods: A population-based sample of healthy 784 men aged 40–49 (202 white Americans, 68 African Americans,
202 Japanese-Americans, and 282 Koreans) was examined in this cross-sectional study. Four regional PWVs were
simultaneously measured by an automated tonometry/plethysmography system.
Results: cfPWV correlated strongly with hf PWV (r = .81, P < .001), but weakly with faPWV (r = .12, P = .001). baPWV
correlated moderately with both hfPWV (r = .47, P < .001) and faPWV (r = .62, P < .001). After stepwise regression
analyses with adjustments for race, cfPWV shared common significant correlates with both hfPWV and fa PWV: systolic
blood pressure (BP) and body mass index (BMI). However, BMI was positively associated with hfPWV and cfPWV, and
negatively associated with faPWV. baPWV shared common significant correlates with hf PWV: age and systolic BP.
baPWV also shared the following correlates with faPWV: systolic BP, triglycerides, and current smoking.
Conclusions: Among healthy men aged 40 – 49, cfPWV correlated strongly with central PWV, and baPWV correlated
with both central and peripheral PWVs. Of the CV risk factors, systolic BP was uniformly associated with all the regional
PWVs. In the associations with factors other than systolic BP, cfPWV was consistent with central PWV, while baPWV was
consistent with both central and peripheral PWVs.
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Increased arterial stiffness is a strong predictor of the
risk for cardiovascular disease in patients with hyper-
tension as well as in the general population independent
of cardiovascular (CV) risk factors [1-4]. Arterial stiff-
ness is mainly related to the aging process and high
blood pressure and can be accelerated by CV risk fac-
tors [5-8].
Arterial stiffness can be noninvasively evaluated by meas-
uring pulse-wave velocity (PWV). The PWV is calculated
using distance and time: the path length between two arter-
ial sites and the amount of time required for the pressure
wave to travel from one arterial site to the next. Carotid-
femoral PWV (cfPWV) measured by Doppler ultrasound
is the most widely used measure of aortic stiffness and is
recognized as the gold standard measure for evaluating ar-
terial stiffness. Alternatively, brachial-ankle PWV (baPWV)
measured by the Omron oscillometric/plethysmographic
system has recently received attention because of its con-
sistently high association with CV risk factors and its ease
of use for large-scale population studies [9-13]. Increased
baPWV has been reported to be an independent predictor
of all-cause mortality in the general population [11], as has
cfPWV [3].
Both cfPWV and baPWV employ arterial sites that
are not consistent with the path of blood flow. To adjust
for this, an assumption is made about the timing of the
pressure wave travelling the opposite direction and this
is used to adjust the measure accordingly. For example,
when measuring cfPWV, the blood does not flow from
the carotid artery to the femoral artery. Thus, an as-
sumption is made that the time that the pressure wave
takes to travel from the heart to the carotid artery is the
same amount of time that it takes a simultaneous wave
to travel the same distance from the heart to the de-
scending aorta. Thus, cfPWV, while using the carotid
and femoral arterial sites, actually represents the velocity
of the pressure wave from the descending aorta to the
femoral artery.
Current technology allows us to simultaneously measure
PWVs between multiple arterial sites. Based on the as-
sumptions used to calculate the measures, cfPWV should
reflect the stiffness of the descending aorta, while baPWV
should reflect the stiffness of both the descending aorta
and the leg artery. To evaluate this, cfPWV and baPWV
can be compared with PWV measures that are more dir-
ectly derived from contiguous points along the path of
blood flow. We have chosen heart-femoral PWV (hfPWV)
as a measure of central (aortic) stiffness and femoral-ankle
PWV (faPWV) as a measure of peripheral (leg) stiffness.
The comparison between baPWV and cf PWV as mea-
sures of arterial stiffness has been reported in a few
studies [12,13]. However, there is no information on
whether both baPWV and cf PWV are comparable witheither hf PWV or faPWV in these measurements of ar-
terial stiffness.
Differentiating central vs. peripheral PWV is important
because they are different pathophysiologically. The central
arteries become stiffer with aging because of a decreased
ratio of elastin to collagen [14-16]. The peripheral arteries
that contain a greater proportion of smooth muscle cells
may not be similarly influenced by aging [7]. However, the
degree to which CV risk factors affect central vs. peripheral
arteries differently is not yet clear. A few studies have re-
ported characteristics of baPWV, hfPWV and faPWV in
their associations with CV risk factors in populations with
hypertension or type II diabetes mellitus [17,18]. However,
no previous studies have reported such differential charac-
teristics between cfPWV vs. baPWV by simultaneously
comparing these with hfPWV or faPWV in healthy popu-
lation groups.
The purpose of this study was to identify the degree
to which the commonly used measures of cfPWV and
baPWV correlated with measures of central and periph-
eral PWVs (i.e., hfPWV and faPWV) which use the arter-
ial sites that are contiguous along the path of blood flow.
In addition, we evaluated whether both cfPWV and
baPWV were consistent with either hfPWV or faPWV in
their associations with CV risk factors. We conducted the
present study in a healthy population sample of White, Af-
rican, and Japanese-American as well as Korean men of
the ERA-JUMP Study.Methods
Study participants
During 2002 to 2006, a population-based sample of
1,022 men aged 40–49 was randomly selected by three
centers of the ERA-JUMP Study: 310 White Americans
and 107 African Americans from Allegheny County,
PA, U.S.; 303 Japanese-Americans from Honolulu, HI,
U.S.; 302 Koreans from Ansan, Gyeonggi-do, South
Korea [19-22]. Originally, the ERA-JUMP study con-
sisted of a population sample of the Japanese population
whose PWV measures had not been examined. All par-
ticipants were without clinical cardiovascular disease or
other severe diseases [19]. For the purpose of recruiting
healthy participants for the present study, we excluded
those with peripheral arterial disease, hypertension,
diabetes, or hyperlipidemia. Of the original samples,
we excluded (1) those having ≤ 0.9 of either left or right
ankle-brachial index (n = 7), (2) those taking antihyperten-
sive, diabetes, or lipid-lowering medications (n = 166);
and (3) those with values missing for all four regional
PWVs (i.e., hf PWV, cf PWV, faPWV, and baPWV)
(n = 62). The final sample was 784 (232 White Americans,
68 African Americans, 202 Japanese-Americans, and 282
Koreans).
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pants. The study was approved by the Institutional Review
Boards of the following institutions: the University of
Pittsburgh, Pittsburgh, PA, U.S.; the Kuakini Medical
Center, Honolulu, HI, U.S.; and Korea University, Seoul,
South Korea.PWV measurement
The PWV was automatically generated using a noninva-
sive and automated waveform analyzer (Colin-VP2000/
1000, Omron, Japan/WaveNexus,TX). This device records
the electrocardiogram (ECG), phonocardiogram, and pres-
sure waveforms. ECG electrodes were placed on both
wrists. A phonocardiogram was placed on the left edge of
the 4th-rib-case; heart sounds S1 and S2 were detected.
Pressure waveforms of the brachial and tibial arteries were
recorded by a plethysmographic sensor and an oscillo-
metric pressure sensor using the occlusion/sensing cuffs
adapted to both arms (i.e., brachial arteries) and both an-
kles (i.e., tibial arteries). Pressure waveforms of the carotid
and femoral arteries were recorded using multiarray to-
nometry sensors placed at the left carotid and the left fem-
oral arteries. Following 10 minutes of rest in a supine
position, pressure waveforms were stored for a sampling
time of 10 seconds with automatic gain analysis and qual-
ity adjustment.
PWV (cm/second) was calculated as (path length
between arterial sites)/(time interval). The path length
for cf PWV was obtained by using the actual distance
of participants’ body (in cm): ([cm from suprasternal
notch to bottom of umbilicus] + [cm from botton of
umbilicus to femoral sensor]) – [cm from carotid to
suprasternal notch]. Furthermore, the path length for the
heart-brachial (Dhb), the heart-femoral (Dhf ), the
heart-ankle (Dha), the femoral-ankle (Dfa), and the
brachial-ankle (Dha – Dhb) segments were obtained using
the following formulas: Dhb = 0.2195×height – 2.0734;
Dhf =0.5643×height – 18.381; Dha= 0.8129×height +
12.328; Dfa = 0.2486×height – 30.709. The PWV re-
sults were obtained with the left sides of cf, ba and fa
sites. Reproducibility of the automated PWV measure-
ment was assessed by the University of Pittsburgh
Ultrasound Research Laboratory, and used 19 and 12
participants for obtaining intraclass and interclass correl-
ation coefficients, respectively. Intraclass correlation co-
efficients of 0.86 (hfPWV), 0.76 (cfPWV), 0.96 (faPWV),
and 0.97 (baPWV) were obtained within technicians. In-
terclass correlation coefficients of 0.93 (hfPWV), 0.73
(cfPWV), 0.87 (faPWV), 0.91 (baPWV) were achieved be-
tween technicians [23].
We standardized the PWV measurement across the 3
centers. Before the study started, staff at the Ultrasound
Research Laboratory, University of Pittsburgh visitedHonolulu to train the sonographers in Honolulu and
from South Korea in PWV measurements.
Other measurements
All participants underwent a physical examination, and
completed a lifestyle questionnaire (e.g., current smokers,
alcohol drinking [two times or greater per week], and
use of anti-hypertensives, diabetic medications, or lipid-
lowering medications) and a laboratory assessment as de-
scribed previously [20]. Venipuncture was performed early
in the clinic visit after a 12-h fast. Samples were storied
at −80°C and shipped on dry ice to the University of
Pittsburgh [20]. Biochemical measurements of the blood
samples were centralized at the Heinz Laboratory of the
University of Pittsburgh. Serum lipids were determined
with the standardized methods according to the Centers
for Disease Control and Prevention, including total cho-
lesterol, low-density-lipoprotein cholesterol (LDL-C), high-
density-lipoprotein cholesterol (HDL-C), and triglycerides
[24]. Serum fasting glucose was determined by a hexo-
kinase -glucose-6-phosphate-dehydrogenase-enzymatic
assay; serum fasting insulin by a radioimmunoassay (Linco
Research Inc., Saint Charles, MO). Blood pressure (BP)
(mmHg) and heart rate (beats per minute) were measured
at right brachial artery in the sitting position after a
5-minute rest with the bladder emptied, by using an auto-
mated sphygmomanometer (BP-8800, Colin Medical Tech-
nology, Komaki, Japan) at the clinic visit. An average of
two measurements was used. All the data collection was
standardized across all 3 centers.
Statistical analysis
We analyzed the pooled data of White Americans (n =
232), African Americans (n = 68), Japanese-Americans
(n = 202), and Koreans (n = 282). Sociodemographic and
clinical characteristics and regional PWVs were described
by using means (standard deviations), medians (interquar-
tile ranges), frequencies, and percentages as appropriately.
To obtain correlation coefficients, we performed the par-
tial correlation analysis with adjustment for age and race.
To examine race-adjusted associations between PWVs and
CV risk factors, we performed multiple regression analysis
by placing each CV risk factor as a predictor variable in
the model after adjusting for race (placed in dummy vari-
ables). Next, to identify CV risk factors associated with
each PWV, we performed stepwise regression analysis with
the backward selection that specified the significance level
(P value > .1) with adjustment for race as a lockterm. The
CV risk factors included as predictor variables into the
models were age, systolic BP, heart rate, body mass index
(BMI), current smoking status, LDL-C, the ratio of total
cholesterol vs. HDL-C, triglycerides (log-transformed), fast-
ing glucose, and fasting insulin (log-transformed). Stat-
istical significance was considered to be P < .05. All
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for Windows (StataCorp LP, College Station, TX).
Results
Participants (N = 784) had a mean age of 45.1years and
a mean BMI of 26.4kg/m2. They had an average of BP
of 122.9/74.7mmHg (Table 1). Of 784 subjects, 21.6%
and 41.6% were current smokers and alcohol drinkers,
respectively.
The PWV values significantly differed by arterial regions
(F = 1,200.0, P < .001) (Figure 1). baPWV had the highest
value, followed by faPWV, hfPWV, and cfPWV (P < .001).
The peripheral faPWV was significantly higher than the
central hf PWV (P < .001) and cf PWV (P < .001).
Age-and race-adjusted correlations between PWVs
All the regional PWVs correlated significantly with each
other. The correlations of cfPWV and baPWV with ei-
ther hfPWV or faPWV were not independent (Table 2).
cfPWV correlated strongly with hfPWV (r = .81, P < .001),
but weakly with faPWV (r = .12, P = .001). baPWV corre-
lated moderately with both hfPWV (r = .47, P < .001) and
faPWV (r = .62, P < .001). According to the data from thisTable 1 Clinical characteristics of the study participants
in 2002–2006 (N = 784)
n (%) Mean (SD)
Race
White Americans 232 (29.5)
African Americans 68 (8.7)
Japanese Americans 202 (25.8)
Koreans 282 (36.0)
Age, years 45.1 (2.9)
Systolic BP, mmHg 122.9 (12.8)
Diastolic BP, mmHg 74.7 (9.9)
Heart rate, beats/min 65.7 (9.3)
BMI, kg/m2 26.4 (4.0)
Total cholesterol, mg/dL 205.6 (38.0)
LDL-C, mg/dL 126.8 (34.5)
HDL-C, mg/dL 48.4 (13.0)
Total cholesterol/HDL-C ratio 4.49 (1.23)
Triglycerides, mg/dL 129.0 (91.0 – 195.0)
Fasting glucose, mg/dL 103.0 (15.6)
Fasting insulin, μIU/dL 11.0 (8.4 – 15.0)
Current smoking 169 (21.6)
Alcohol drinking 326 (41.6)
Values are expressed as means (standard deviations) or median (interquartile
range) for continuous variables and total number (percentages) for
categorical variables.
BMI body mass index, BP blood pressure, HDL-C high density lipoprotein
cholesterol, LDL-C low density lipoprotein cholesterol, SD standard deviation.correlation matrix, cf PWV mostly reflected properties
of central arterial stiffness, while baPWV reflected mixed
properties of both central and peripheral arterial stiff-
ness. baPWV moderately correlated with cfPWV (r = .42,
P < .001). Meanwhile, the correlation between hf PWV
and faPWV was also significant, but minimal (r = .08,
P = .030).
Race-adjusted associations of CV risk factors with regional
PWVs
Age was significantly and positively associated with
hfPWV and baPWV (Table 3). Systolic BP and heart rate
were significantly and positively associated with all the
regional PWVs. Similarly, triglycerides and fasting insu-
lin were significantly and positively associated with all
the regional PWVs; however, LDL-C was not signifi-
cantly associated with any regional PWV.
BMI was significantly and positively associated with
hfPWV, cfPWV, and baPWV, but not with faPWV. Current
smoking was significantly and positively associated with
faPWV and baPWV.
Multivariable adjusted associations of CV risk factors with
regional PWVs
After the stepwise regression analyses with adjustments
for race, the CV risk factors of age, systolic BP, BMI, heart
rate, triglycerides, and current smoking were included in
the regression models as significant correlates for at least
one regional PWV (Table 4). Significant correlates for
hfPWV were age, systolic BP, and BMI. Significant corre-
lates for cfPWV were systolic BP and BMI. Significant cor-
relates for faPWV were systolic BP, BMI, triglycerides, and
current smoking. Significant correlates for baPWV were
age, systolic BP, heart rate, triglycerides, and current smok-
ing. As a result, all the regional PWVs had a common sig-
nificant correlate, i.e., systolic BP. In particular, cfPWV
shared common correlates with both hfPWV and faPWV
(i.e., systolic BP and BMI). However, BMI was significantly
and positively associated with hfPWV and cfPWV, and
negatively associated with faPWV. Meanwhile, baPWV
shared common correlates with hfPWV (i.e., age and sys-
tolic BP) and also with faPWV (i.e., systolic BP, triglycer-
ides, and current smoking).
Finally, based on R2 values in the multivariable adjusted
models, the CV risk factors explained 21%, 19%, 21%, and
34% of the total variances in hfPWV, cfPWV, faPWV, and
baPWV, respectively (Table 4).
Discussion
Among healthy men aged 40 – 49, cfPWV correlated
significantly and strongly with central hfPWV, whereas
baPWV correlated significantly and moderately with both
central hfPWV and peripheral faPWV. In the associations
with CV risk factors, cfPWV shared common significant
Figure 1 Region-specific distribution of pulse wave velocity (N = 784). PWV = pulse wave velocity, hf = heart-femoral, cf = carotid-femoral,
fa = femoral-ankle, ba = brachial-ankle. Each line on a box indicates a median value of each regional PWV. F and P values indicate significant
difference across all the regional PWVs.
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BMI. However, BMI was positively associated with hfPWV
and cfPWV, and negatively associated with faPWV. Mean-
while, baPWV shared common significant correlates with
hfPWV, i.e., age and systolic BP, and also with faPWV, i.e.,
systolic BP, triglycerides, and current smoking. Thus, sys-
tolic BP was uniformly associated with all the regional
PWVs. cfPWV was consistent with central hfPWV, while
baPWV was consistent with both central and peripheral
PWVs in their associations with CV risk factors other than
systolic BP.
We found that the peripheral arteries were stiffer than
the aorta in our participants of men aged 40 – 49 based on
the regional PWV values. Generally, such a difference is
present in younger and middle-aged populations but not in
older populations [25]. The Framingham Heart Study re-
vealed that carotid-brachial PWV was greater than cfPWV
in that segment of the aorta and the proximal central ar-
tery in the < 60 aged group, but cfPWV exceeded carotid-
brachial PWV in the > 60 aged group of 521 men and
women [16]. These results may be dependent on age-Table 2 Correlationsa between regional pulse wave
velocity values (N = 784)
Regional PWV r (P value)
hf PWV cf PWV faPWV baPWV
hf PWV 1.00
cf PWV 0.81 (<.001) 1.00
faPWV 0.08 (.030) 0.12 (.001) 1.00
baPWV 0.47 (<.001) 0.42 (<.001) 0.62 (<.001) 1.00
aPartial correlation was performed with adjustment for age and race.
PWV pulse wave velocity, hf heart-femoral, cf carotid-femoral,
fa femoral-ankle, ba brachial-ankle.related decreases in the regional distribution of elastin con-
tents found in the central elastic arteries. Studies have re-
ported that the slope of the age-related increase in stiffness
by arterial segments was greater in the aorta than in
upper-limb or lower-limb arteries [25].
In our participants aged 40 – 49, baPWV reflected mixed
properties of the aortic and peripheral arteries, which can
be primarily explained by the results of the correlation co-
efficients of baPWV with each of hfPWV (r = .47), cfPWV
(r = .42), and faPWV (r = .62). Sugawara et al. [13] com-
pared baPWV with both cf PWV and faPWV in 406
Japanese healthy adults aged 18 – 76 years, and re-
ported correlation coefficients between baPWV and
cfPWV (r = .76) and between baPWV and faPWV (r = .76).
Compared to the present study, the relatively greater
magnitude of correlation between baPWV and cfPWV
may be due to a wider age range of their study population.
In this context, baPWV may reflect properties of aortic
stiffness in a gradually increasing manner with aging. More-
over, baPWV also reflects the properties of the proximal
brachial arteries which are used to derive this measure. A
few studies, including the Bogalusa Heart Study, reported
that the proximal brachial arteries, similar to elastic carotid
arteries, had an age-related decrease in distensibility, sug-
gesting that they may behave differently from other mus-
cular arteries (e.g., femoral or radial arteries) [14,26-28].
baPWV was significantly associated with CV risk factors
such as age, systolic BP, heart rate, triglycerides levels, and
current smoking status, some of which were common
factors with either hfPWV or faPWV. Moreover, baPWV
was explained by these CV factors with relatively greater
variance (R2 = .34) compared to hfPWV (R2 = .21), cfPWV
(R2 = .19), and faPWV (R2 = .21). Tsuchikura et al. [17]
Table 3 Associationsa between regional pulse wave velocity and cardiovascular risk factors (N = 784)
Beta (P value)
hf PWV cf PWV faPWV baPWV
Age, years .15 (<.001) .06 (.074) .05 (.187) .09 (.012)
Systolic BP, mmHg .39 (<.001) .31 (<.001) .33 (<.001) .47 (<.001)
Heart rate, beats/min .09 (.016) .11 (.002) .18 (<.001) .21 (<.001)
BMI, kg/m2 .23 (<.001) .31 (<.001) .02 (.526) .18 (<.001)
LDL-C, mg/dL .06 (.121) -.01 (.697) -.01 (.721) .01 (.692)
Total cholesterol/HDL-C ratio .11 (.003) .12 (.001) .05 (.131) .12 (<.001)
Triglycerides, mg/dL .16 (<.001) .18 (<.001) .20 (<.001) .27 (<.001)
Fasting glucose, mg/dL .06 (.111) .06 (.080) .08 (.020) .10 (.003)
Fastinginsulin, μIU/dL .15 (<.001) .16 (<.001) .08 (.026) .16 (<.001)
Current smoking, (%) .03 (.398) .06 (.116) .12 (.002) .09 (.012)
Alcohol drinking, (%) -.00 (.983) -.04 (.308) .10 (.005) .06 (.075)
aResulted from the multiple regression analysis after adjustment for race. BMI body mass index, BP blood pressure, HDL-C high density lipoprotein cholesterol,
LDL-C low density lipoprotein cholesterol, PWV pulse wave velocity, hf heart-femoral, cf carotid-femoral, fa femoral-ankle, ba brachial-ankle.
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hfPWV and faPWV in associations with CV factors in
2,806 participants, including patients with diabetes melli-
tus, hypertension, or chronic kidney disease. baPWV,
hfPWV, and faPWV shared the risk factors of higher age
and the presence of diabetes and chronic kidney disease.
Meanwhile, even though the mechanism explaining the
predictive ability of baPWV for the risk of cardiovascular
diseases is still unclear, Vlachopoulos et al. [29] have dem-
onstrated in a meta-analysis that an increase in baPWV of
100cm/sec corresponded with an increase of 12%, 13%,
and 6% in total cardiovascular events, cardiovascular
mortality, and all-cause mortality, respectively. Therefore,
the potential of baPWV in the associations with CVTable 4 Stepwise regression analysisa: Associations between pu
beta P value R2
hf PWV .21
Age .14 <.001
Systolic BP .36 <.001
BMI .10 .009
Triglycerides .07 .062
faPWV .21
Systolic BP .32 <.001
BMI -.13 .001
Heart rate .07 .051
Triglycerides .15 <.001
Current smoking .09 .010
BP blood pressure, BMI body mass index, LDL-C low density lipoprotein cholesterol,
fa femoral-ankle, ba brachial-ankle.
aThe stepwise regression was performed for backward removal (p < .1) after adjusti
triglycerides, total cholesterol/HDL-C ratio, glucose, insulin, current smoking, and alc
were log-transformed.risk should be further studied pathophysiologically and
methodologically.
As expected, the association of age with arterial stiff-
ness differed by arterial segments. Age was significantly
associated with aortic stiffness (i.e., hfPWV), rather than
peripheral and muscular arteries (i.e., faPWV). As re-
ported consistently in previous studies [7,15], the large
elastic arteries near the heart stiffen with age by the rea-
son of a decrease in elastin content. On the other hand,
peripheral muscular arteries may be less or not affected
by age because of their more vascular smooth muscle
cells and less elastin, although there have been some
controversies [7]. Unlike previous findings [14], our find-
ing showed a lack of the significant association betweenlse wave velocity and cardiovascular risk factors (N = 784)
beta P value R2
cf PWV .19
Age .63 .062
Systolic BP .23 <.001
BMI .21 <.001
Triglycerides .06 .075
Current smoking .06 .085
baPWV .34
Age .09 .003
Systolic BP .42 <.001
Heart rate .09 .005
Triglycerides .16 <.001
Current smoking .06 .049
PWV pulse wave velocity, hf heart-femoral, cf carotid-femoral,
ng for race as a lockterm. Each model includes age, systolic BP, heart rate, BMI,
ohol drinking as predictor variables. Triglycerides and fasting insulin
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cfPWV within one-decade aged group (i.e., 40-49years).
Our results have shown that systolic BP was associated
with both aortic stiffness as measured by hfPWV and
peripheral stiffness as measured by faPWV. Previously,
Cecelja et al. [8] confirmed in a meta-analysis of 12 stud-
ies that BP was independently associated with cfPWV,
and the contribution of standard CV risk factors other
than age and BP were small or nonsignificant in multi-
variable regression models. Meanwhile, our data showed
that the magnitude of the association between systolic
BP and faPWV (beta = .32) was similar to that between
systolic BP and hf PWV (beta = .36), which paralleled the
findings of previous studies [30,31].
In our study, triglycerides and smoking were signifi-
cantly and positively associated with faPWV, but not with
hfPWV. Previously, no studies have reported such associa-
tions of CV risk factors with peripheral (leg) stiffness com-
pared to aortic stiffness in a healthy population. Kimoto
et al. [18] reported associations of CV risk factors with
hfPWV vs. faPWV among 161 diabetes patients and 129
healthy subjects. As a result, age and BP were significantly
associated with both hfPWV and faPWV, whereas the
presence of type II diabetes was significantly associated
only with hfPWV [18]. In addition, the relation of the
stiffness of the peripheral (leg) artery to cardiovascular
outcomes has been found to be nonsignificant in patients
with certain diseases [30,32]. Tillin et al. [30] reported no
significant associations of faPWV with coronary calcifica-
tion and carotid intima-media thickness in patients with
coronary artery disease, in contrast to significant associa-
tions of cfPWV. Thus, compared to aortic PWV, the clin-
ical importance of the peripheral PWV remains to be still
established.
We found that there was an inverse association be-
tween BMI and faPWV. In several cross-sectional stud-
ies, increased BMI has been reported to be positively
associated with the aortic stiffness measured by cfPWV
[5,33,34], which parallels with the positive associations
of BMI with each of hf PWV and cfPWV in our present
study. However, no previous studies reported the associ-
ation between BMI and peripheral stiffness. A few stud-
ies have reported a negative association between baPWV
and BMI. Tomiyama et al. [10] reported that baPWV
was significantly and negatively associated with BMI
among 7,881 healthy Japanese men, but not among the
women. Physiologically, arterial stiffness may be related
to the distensibility and arterial diameter of the artery.
Zebekakis et al. [33] reported that BMI was related to in-
creased diameter and decreased distensibility in femoral
arteries, and this increased diameter associated with
BMI was significantly greater in middle-aged men (age
40) than in older aged men (age 60). Weight gain may
be related to increased regional blood flow to adiposeand non-adipose tissues [35]. Therefore, the inverse associ-
ation between peripheral PWVs and BMI may be attribut-
able to the effort of increasing the diameters of peripheral
arteries, a compensating mechanism to minimize de-
creased distensibility in middle-aged men.
The strengths of the study include the fact that this is the
first study to explore differential characteristics of cfPWV
and baPWV by simultaneously comparing these with the
central and peripheral PWVs in a healthy middle-aged
group. The limitations of the study include the cross-
sectional nature of the study design, which cannot distin-
guish between cause and effect, especially between BP and
PWV. The limited age range (i.e., 40–49 years) and only
male population may lead to lack of generalizability for our
findings to populations of wider age ranges and to female
populations. In addition, we used the formula for calculat-
ing the path lengths for hfPWV, faPWV and baPWV,
which was derived from the body sizes of the Japanese
population. This formula may not be always congruent with
body sizes of the White American or African American
male population groups.
Conclusions
Among healthy men aged 40 – 49 years, cfPWVcorrelated
strongly with central PWV, and baPWV correlated with
both central and peripheral PWVs. In the associations with
CV risk factors, cfPWV was consistent with central PWV,
while baPWV was consistent with both central and per-
ipheral PWVs. Therefore, cfPWV mostly reflected proper-
ties of central arterial stiffness, while baPWV reflected
mixed properties of both central and peripheral arterial
stiffness.
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